Gara Jalqabaatti › Leukemia Biphenotypicii Hamaa
Qorannoo klinikaalii Leukemia Biphenotypicii Hamaa Ameerikaa Keessatti hirmaatuu
Qorannoo 37 Leukemia Biphenotypicii Hamaa f bakka adda addaa Ameerikaa Keessatti hirmaatuu jiru.
Magaalota qorannoo baay'ee qaban
- Seattle, WAQorannoo 15
- Houston, TXQorannoo 11
- New York City, NYQorannoo 10
- Atlanta, GAQorannoo 9
- Durham, NCQorannoo 8
- Memphis, TNQorannoo 7
- Chicago, ILQorannoo 7
- Charlotte, NCQorannoo 6
- Aurora, COQorannoo 6
- Baldwin Park, CAQorannoo 6
- Portland, ORQorannoo 6
- Los Angeles, CAQorannoo 6
- Philadelphia, PAQorannoo 6
- Dallas, TXQorannoo 6
- San Diego, CAQorannoo 5
- Boston, MAQorannoo 5
- San Francisco, CAQorannoo 5
- Tampa, FLQorannoo 5
- Clifton, NJQorannoo 5
- Columbus, OHQorannoo 5
- Nashville, TNQorannoo 5
- Greenburgh, NYQorannoo 5
- Cincinnati, OHQorannoo 5
- Fort Worth, TXQorannoo 5
- Minneapolis, MNQorannoo 5
- Mountain View, CAQorannoo 4
- Jacksonville, FLQorannoo 4
- Denver, COQorannoo 4
- Milwaukee, WIQorannoo 4
- Greenville, NCQorannoo 4
- St. Louis, MOQorannoo 4
- Kansas City, MOQorannoo 4
- Omaha, NEQorannoo 4
- Akron, OHQorannoo 4
- Miami, FLQorannoo 4
- Orange, CAQorannoo 4
- Louisville, KYQorannoo 4
- Gainesville, FLQorannoo 4
- Washington, DCQorannoo 4
- Edison, NJQorannoo 4
Naannoon
- AlabamaQorannoo 3
- AlaskaQorannoo 3
- ArizonaQorannoo 3
- ArkansasQorannoo 3
- CaliforniaQorannoo 15
- ColoradoQorannoo 8
- ConnecticutQorannoo 3
- DelawareQorannoo 3
- Distaarikii KoloombiyaaQorannoo 4
- FloridaQorannoo 9
- GeorgiaQorannoo 9
- HawaiiQorannoo 3
- IdahoQorannoo 3
- IllinoisQorannoo 7
- IndianaQorannoo 4
- IowaQorannoo 4
- KentuckyQorannoo 4
- LouisianaQorannoo 4
- MaineQorannoo 3
- MarylandQorannoo 4
- MassachusettsQorannoo 5
- MichiganQorannoo 4
- MinnesotaQorannoo 6
- MississippiQorannoo 3
- MissouriQorannoo 5
- NebraskaQorannoo 4
- NevadaQorannoo 3
- New HampshireQorannoo 3
- New JerseyQorannoo 6
- New YorkQorannoo 11
- North CarolinaQorannoo 11
- North DakotaQorannoo 3
- OhioQorannoo 8
- OklahomaQorannoo 5
- OregonQorannoo 6
- PennsylvaniaQorannoo 6
- Rhode IslandQorannoo 3
- South CarolinaQorannoo 3
- South DakotaQorannoo 3
- TennesseeQorannoo 10
- TexasQorannoo 13
- UtahQorannoo 3
- VirginiaQorannoo 3
- WashingtonQorannoo 15
- West VirginiaQorannoo 3
- WisconsinQorannoo 5
Qorannoo yeroo dhihootti haaromfaman
Takkalaa qorannoo (Ingiliffa)
A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 12 hanga 78 · Saalaa hunda · Haaromfame 29-Ful-2026 · NCT03802695Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
Namoota walitti qabaa jiraSadarkaa 2
365 Days · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06317662CLAG-M or FLAG-Ida Chemotherapy and Reduced-Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelomonocytic Leukemia
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 17-Ful-2026 · NCT04375631Randomization for the Identification of Best Treatment Intensity for Less Fit Adults With Acute Myeloid Leukemia and Myeloid Neoplasms
Namoota walitti qabaa jira
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 17-Ful-2026 · NCT07094750A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
Namoota walitti qabaa jiraSadarkaa 1/2
30 Days · Saalaa hunda · Haaromfame 16-Ful-2026 · NCT04065399Enasidenib and Azacitidine in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia and IDH2 Gene Mutation
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 14-Ful-2026 · NCT03683433Phase I/II Trial: Engineered Donor Graft (Orca Q) for Pediatric Hematopoietic Cell Transplant (HCT)
Namoota walitti qabaa jiraSadarkaa 1/2Hojjettoota fayyaa simatamoo
Hanga umuriin 50 · Saalaa hunda · Haaromfame 01-Ful-2026 · NCT05322850Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
Namoota walitti qabaa jiraSadarkaa 3
365 Days – 25 Years · Saalaa hunda · Haaromfame 25-Hag-2026 · NCT03959085The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Namoota walitti qabaa jiraSadarkaa 1/2
Hanga umuriin 22 · Saalaa hunda · Haaromfame 25-Hag-2026 · NCT04726241Adding Dasatinib Or Venetoclax To Improve Responses In Children With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (ALL) Or Lymphoma (T-LLY) Or Mixed Phenotype Acute Leukemia (MPAL)
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 1 hanga 18 · Saalaa hunda · Haaromfame 10-Hag-2026 · NCT06390319Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 13 hanga 90 · Saalaa hunda · Haaromfame 06-Hag-2026 · NCT06533579Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 1 hanga 30 · Saalaa hunda · Haaromfame 03-Hag-2026 · NCT06177067Personalized NK Cell Therapy in CBT
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 15 hanga 80 · Saalaa hunda · Haaromfame 30-Ado-2026 · NCT02727803Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Diseases
Namoota walitti qabaa jiraSadarkaa 2
6 Months – 65 Years · Saalaa hunda · Haaromfame 22-Ado-2026 · NCT06013423Combination Chemotherapy (FLAG-Ida) Followed Immediately by Reduced-Intensity Total Body Radiation Therapy and Donor Hematopoietic Cell Transplant for the Treatment of Adults Age 60 and Older With Newly Diagnosed Adverse-Risk Acute Myeloid Leukemia or Other High-Grade Myeloid Cancer
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 20-Ado-2026 · NCT07046078Identification of Necessary Information for Treatment Induction in Newly Diagnosed Acute Lymphoblastic Leukemia/Lymphoma
Namoota walitti qabaa jiraSadarkaa 4
Umuriin 1 hanga 18 · Saalaa hunda · Haaromfame 14-Ado-2026 · NCT06289673Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 07-Ado-2026 · NCT07216443Allo HSCT Using RIC and PTCy for Hematological Diseases
Namoota walitti qabaa jiraSadarkaa 2
Hanga umuriin 75 · Saalaa hunda · Haaromfame 06-Ado-2026 · NCT05805605Registry of Older Patients With Cancer
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 65 fi ol · Saalaa hunda · Haaromfame 29-Wax-2026 · NCT01137825Trial for Patients w/ Advanced Hematologic Malignancies Undergoing Allogeneic HCT
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 hanga 70 · Saalaa hunda · Haaromfame 23-Wax-2026 · NCT06551584211^At-BC8-B10 Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, or Mixed-Phenotype Acute Leukemia
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 22-Wax-2026 · NCT03128034211At-BC8-B10 Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Acute Leukemia or Myelodysplastic Syndrome
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 22-Wax-2026 · NCT03670966A Study of Revumenib and Mezigdomide in People With Leukemia
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 12 fi ol · Saalaa hunda · Haaromfame 22-Wax-2026 · NCT07356154Cladribine, Idarubicin, Cytarabine, and Quizartinib in Treating Patients With Newly Diagnosed, Relapsed, or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 12-Wax-2026 · NCT04047641Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies
Namoota walitti qabaa jiraSadarkaa 2Hojjettoota fayyaa simatamoo
6 Months · Saalaa hunda · Haaromfame 29-Cam-2026 · NCT04195633Kanneen ClinicalTrials.gov irraa argaman, daataa 05-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.